<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation inhibitors U74006F (21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16 alpha-methylpregna-1,4,9]-(11)-triene-3, 20-dione) and U74512E (21-[4-(3-ethylamino-2-<z:chebi fb="0" ids="51635">pyridinyl</z:chebi>)-1-piperazinyl]-16 alpha-methylpregna- 1,4,9]-(11)-triene-3,20-dione) were tested for cerebroprotective properties in the rat </plain></SENT>
<SENT sid="1" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced by irreversible occlusion of the middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>-O) </plain></SENT>
<SENT sid="2" pm="."><plain>The 21-aminosteroids U74006F (1 mg/kg or 10 mg/kg, i.p.) and U75412E (1 mg/kg or 30 mg/kg, i.p.) were injected 30 min prior and 2, 6, and 24 h after <z:chebi fb="70" ids="34342">MCA</z:chebi>-O </plain></SENT>
<SENT sid="3" pm="."><plain>The higher doses of U74006F or U75412E caused reductions in cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> size ranging from 28 to 34% </plain></SENT>
<SENT sid="4" pm="."><plain>The data suggest the 21-aminosteroids to be mildly effective after irreversible occlusion of the <z:chebi fb="70" ids="34342">MCA</z:chebi> but possibly to be more beneficial as part of a combined drug therapy in conjunction with <z:chebi fb="0" ids="29108">Ca2+</z:chebi> or <z:chebi fb="0" ids="31882">NMDA</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> </plain></SENT>
</text></document>